Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for
and early detection of cervical cancer and reduce its burden globally. To inform WHO self …

Introduction Population coverage for cervical cancer screening is an important determinant
explaining differences in the incidence of cervical cancer between countries. Offering …

Objective To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV)
assays on self samples and the efficacy of self sampling strategies to reach underscreened …

Background Human papillomavirus (HPV) testing on self-samples represents a great
opportunity to increase cervical cancer screening uptake among under-screened women …

Background Human papillomavirus (HPV) testing on self-collected samples is a potential
alternative to HPV testing on clinician-collected samples, but non-inferiority of its clinical …

In most industrialized countries, screening programs for cervical cancer have shifted from
cytology (Pap smear or ThinPrep) alone on clinician-obtained samples to the addition of …

The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

Objective To provide a focused critical review of the literature on the acceptability, feasibility,
and uptake of human papillomavirus (HPV) self-sampling among hard-to-reach women …

Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …